[ET Net News Agency, 16 September 2024] EVEREST MED-B (01952) fell 9.6% to HK$21.25,
dipping below the 250-D SMA of HK$21.75.
It hits an intra-day low of HK$21.15, and an intra-day high of HK$23.65. The total
shares traded was 1.19 million, with a value of HK$26.32m. The active buy/sell ratio is
30:70, with net selling turnover of HK$9.55m. FUTU SEC INT'L accounts for greatest net
responsive buying turnover of HK$3.53m, with volume weighted average price of HK$22.185.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$1.51m,
with volume weighted average price of HK$21.823.

Basic Information
=================

---------------------------------
Nominal 21.250 % Chg -9.57%
High 23.650 Low 21.150
Shares Tr 1.19m Turnover 26.32m
10-D SMA 22.680 %H.V 51.911
20-D SMA 21.241 VWAP 22.072
50-D SMA 20.174 RSI14 49.630
---------------------------------
Status: Dipping below the 250-D SMA, active buy/sell ratio is 30:70, with net selling
turnover of HK$9.55m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 21.25 -9.57
IMMUNEONCO-B (01541) 6.79 +37.45
KEYMED BIO-B (02162) 38.00 -4.40
WUXI XDC (02268) 20.25 +0.75
ASCENTAGE-B (06855) 32.80 -1.94
SKB BIO-B (06990) 177.50 -2.95
ZAI LAB (09688) 16.02 Unchanged
AKESO (09926) 66.40 +7.70
INNOCARE (09969) 5.54 -3.99
REMEGEN (09995) 10.48 -18.76
---------------------------------------------
(ed)